Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes-Reference-Cited by-同舟云学术

Architecture of autoinhibited and active BRAF–MEK1–14-3-3 complexes

Published:2019-10-03 Issue:7783 Volume:575 Page:545-550
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Park Eunyoung,Rawson Shaun,Li Kunhua,Kim Byeong-Won,Ficarro Scott B.,Pino Gonzalo Gonzalez-Del,Sharif Humayun,Marto Jarrod A.,Jeon Hyesung,Eck Michael J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1660-y.pdf

Reference55 articles.

1. Lavoie, H. & Therrien, M. Regulation of RAF protein kinases in ERK signalling. Nat. Rev. Mol. Cell Biol. 16, 281–298 (2015).

2. Simanshu, D. K., Nissley, D. V. & McCormick, F. RAS proteins and their regulators in human disease. Cell 170, 17–33 (2017).

3. Terrell, E. M. & Morrison, D. K. Ras-mediated activation of the Raf family kinases. Cold Spring Harb. Perspect. Med. 9, a033746 (2019).

4. Holderfield, M., Deuker, M. M., McCormick, F. & McMahon, M. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat. Rev. Cancer 14, 455–467 (2014).

5. Sanchez-Vega, F. et al. Oncogenic signaling pathways in The Cancer Genome Atlas. Cell 173, 321–337 (2018).

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversible control of kinase signaling through chemical-induced dephosphorylation;Communications Biology;2024-08-31

2. Capturing RAS oligomerization on a membrane;Proceedings of the National Academy of Sciences;2024-08-15

3. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

4. Effector Binding Sequentially Alters KRAS Dimerization on the Membrane: New Insights Into RAS‐Mediated RAF Activation;Advanced Science;2024-08-13

5. Signaling from RAS to RAF: The Molecules and Their Mechanisms;Annual Review of Biochemistry;2024-08-02